Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorder

Importance: Individuals with schizophrenia are at higher risk for severe COVID-19 illness and severe breakthrough infection following vaccination. It is unclear whether immune response to vaccination differs in this population. Objective: To assess whether anti-SARS-CoV-2 spike antibody titers after...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Katlyn Nemani, Livia De Picker, Faith Dickerson, Marion Leboyer, Michele Santacatterina, Fumika Ando, Gillian Capichioni, Thomas E. Smith, Jamie Kammer, Kawtar El Abdellati, Manuel Morrens, Violette Coppens, Emily Katsafanas, Andrea Origoni, Sabahat Khan, Kelly Rowe, R.Sarah Ziemann, Ryad Tamouza, Robert H. Yolken, Donald C. Goff
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2024-07-01
Serie:	Brain, Behavior, & Immunity - Health
Soggetti:	Schizophrenia Schizoaffective disorder COVID-19 mRNA vaccine Immunogenicity Antibody response
Accesso online:	http://www.sciencedirect.com/science/article/pii/S2666354624000802
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!